USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Enplas Corporation

USPTO PatentsView assignee record - 367 granted patents across 74 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).

RSS updates for this company

The verdict

According to USPTO PatentsView, Enplas ranks #1,157 of 49,997 tracked US assignees by granted-patent volume, with 367 patents across 74 technology areas.

#1,157
of 49,997 US assignees by volume
Top 7%
by Innovation Score (55.1/100)
8.1
avg claims per patent
-12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1157 · Foreign Corporation #1,157 · 367 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 367 grants
  • TOP-DECILE #1,157/49,997
  • PHOTO-FINISH Convida Wireless
  • CPC-WIDE G02B · 74 areas
  • INNOV-PAR 55.1/100
  • CLAIMS-PAR 8.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -12% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Convida Wireless, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Enplas

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Enplas's Innovation Score is 55.1/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Enplas's grant cadence moved

Between 2020–2024, Enplas Corporation received 167 grants versus 189 in 2015–2019 (-12% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 51 grants and bottomed in 2021 at 25. Lead class G02B accounts for 38.4% of the portfolio across 74 subclasses. Volume neighbours: St. Jude Medical, Atrial Fibrillation Division, Inc. (#1,153) and Westinghouse Electric Company LLC (#1,161).

Enplas's three-year grant acceleration

From 2019–2021 to 2022–2024, Enplas Corporation moved from 126 to 91 grants (0.72x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,079. See the growth leaderboard.

Who files at Enplas's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Enplas holds 367 patents at rank #1,157, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Enplas

By rank, the assignees closest to #1,157 in granted patent volume.

Leaders in G02B (Optical Elements)

Other assignees with the most granted patents in Enplas's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Enplas, neither rank-band nor same-CPC leaders (those blocks stay above).

Enplas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0102030405060 20152016201720182019202020212022202320242025 11
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Enplas Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 27 7.4%
2016 42 11.4%
2017 32 8.7%
2018 38 10.4%
2019 50 13.6%
2020 51 13.9%
2021 25 6.8%
2022 35 9.5%
2023 30 8.2%
2024 26 7.1%
2025partial year 11 3.0%

Which technologies does Enplas Corporation patent most?

Top 15 of 74 technology areas

Where it ranks

Overall rank by patents

#1,157

of 49,997 tracked assignees

Innovation Score

55.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Enplas Corporation's patent record in context - here's where to go next.

  • Enplas Corporation's lead technology class is G02B (Optical Elements, Systems OR Apparatus), 38.4% of its portfolio - see every assignee active in that class. Explore G02B
  • Ranked #1,157 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Enplas Corporation against St. Jude Medical, Atrial Fibrillation Division, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 55.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.